» Articles » PMID: 34409196

Epstein-Barr Virus Induced Post-transplant Lymphoproliferative Disorder Presenting with Unilateral Retinal Involvement

Overview
Specialty Ophthalmology
Date 2021 Aug 19
PMID 34409196
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Post-transplant lymphoproliferative disorder (PTLD) represents a spectrum of disorders associated with Epstein Barr Virus infection in up to 80% of cases in the setting of pharmacologic immunosuppression following hematopoietic stem cell or solid organ transplantation. Ocular involvement is a rare finding in PTLD.

Observation: We report the case of a 38-year-old man who presented with unilateral retinal infiltrates as first manifestation of PTLD relapse. Diagnosis relied on the presence of EBV DNA in anterior chamber fluids and vitrectomy that showed the presence of a B cell clone. Systemic relapse of PTLD was detected 12 weeks after retinal findings. Treatment of ocular disease included systemic injections of rituximab and intravitreal injections of methotrexate, halting the extension of retinal infiltrates.

Conclusion: Ocular involvement in PTLD is rare and needs to be acknowledged because it can precede a systemic relapse of the hematological condition.

Citing Articles

Case report: A rare EBV-associated T/NK cell monomorphic posttransplant lymphoproliferative disorder.

Jiang X, Zhang Y, Li X, Li X, Li Z, Meng W Front Immunol. 2024; 15:1491681.

PMID: 39512350 PMC: 11540687. DOI: 10.3389/fimmu.2024.1491681.


Epstein-Barr virus-positive iris diffuse large B-cell lymphoma detected by metagenomic next-generation sequencing.

Wang X, Hong J, Xu Y, Zhang P, Li Y, Dou H BMC Ophthalmol. 2024; 24(1):99.

PMID: 38438866 PMC: 10913400. DOI: 10.1186/s12886-024-03334-8.

References
1.
Demols P, Cochaux P, Velu T, Caspers-Velu L . Chorioretinal post-transplant lymphoproliferative disorder induced by the Epstein-Barr virus. Br J Ophthalmol. 2001; 85(1):93-5. PMC: 1723697. DOI: 10.1136/bjo.85.1.93. View

2.
Walton R, Onciu M, Irshad F, Wilson T . Conjunctival posttransplantation lymphoproliferative disorder. Am J Ophthalmol. 2007; 143(6):1050-1. DOI: 10.1016/j.ajo.2007.01.038. View

3.
Fujimoto A, Suzuki R . Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders after Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical Outcomes. Cancers (Basel). 2020; 12(2). PMC: 7072403. DOI: 10.3390/cancers12020328. View

4.
Loren A, Porter D, Stadtmauer E, Tsai D . Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant. 2003; 31(3):145-55. DOI: 10.1038/sj.bmt.1703806. View

5.
Pagliuca S, Bommier C, Michonneau D, Meignin V, Salmona M, Robin M . Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2019; 25(12):2490-2500. DOI: 10.1016/j.bbmt.2019.08.006. View